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The B cell receptor (BCR) activates the ERK kinases, but what does ERK do? In this issue of Immunity,
Yasuda et al. (2008) show that ERK controls a transcription factor network by which the pre-BCR drives early
B cell development.The signaling pathway leading from the
Ras GTPase to the extracellular signal-
regulated kinases (ERK1 and ERK2) is ac-
tivated by the B cell receptor (BCR) and by
the surrogate light chain (SLC)-containing
pre-B cell receptor (pre-BCR) found on
B cell progenitors. In vitro studies using
chemical inhibitors revealed that ERK ac-
tivity is important for the pre-BCR to col-
laborate with IL-7 to drive pre-B cell prolif-
eration (Fleming and Paige, 2001) and for
BCR-induced proliferation of splenic B
cells (Richards et al., 2001). However,
the role of ERK in B cell development
and activation in vivo has been hard to as-
sess given the redundant, but essential,
functions of ERK1 and ERK2. Moreover,
ERK1 and ERK2 have many substrates,
making it difficult to determine which con-
trols specific cellular responses. By indu-
cibly disrupting the gene encoding ERK2
in mice already deficient for ERK1, Ya-
suda et al. (2008) bypassed the require-
ment for ERK2 in placental development
and showed that ERK signaling is re-
quired for pre-BCR-induced differentia-
tion of pro-B cells into pre-BII cells and
for the subsequent proliferation of pre-
BII cells (Figure 1). Importantly, they con-
nect the dots, showing that ERK signaling
links Syk- and Zap70-dependent pre-
BCR signaling to phosphorylation of the
Elk and CREB transcription factors, which
induce the expression of other transcrip-
tion factors that promote pre-BII cell pro-
liferation (Figure 1).
The transition frompro-B topre-BII cells,
more specifically the maturation of pre-
BCR-expressing transitional pre-BI cells
into large proliferating pre-BII cells, is the
first checkpoint (checkpoint I) in early B
cell development. Production of a func-
tional Ig heavy chain (IgH) is assessed by
the ability to form a signaling-competent
pre-BCR.Theconstitutivepre-BCRsignal-488 Immunity 28, April 2008 ª2008 Elseviering in transitional pre-BI cells promotescell
survival, terminates VDJ recombination to
ensure Igh allelic exclusion, and drives
phenotypic maturation to the CD2+CD25+
pre-BII stage. Pre-BCR signaling also al-
lows IL-7 to induce several rounds of pre-
BII cell proliferation. This expands the
BCR repertoire because each daughter
cell generates a different Ig light chain.
Checkpoint I is a crucial test for B cell
progenitors.Disruptinganyof theproximal
pre-BCR signaling components arrests
development at this step. This occurs
when the genes encoding IgH or the l5
SLC are disrupted, when the Iga- and
Igb-containing signaling subunit (Iga-Igb)
of the pre-BCR is replaced with versions
lacking the immunoreceptor tyrosine-
based activation motifs (ITAMs) that re-
cruit tyrosine kinases, andwhen the genes
encoding the Syk and Zap70 tyrosine ki-
nases are disrupted (Jumaa et al., 2005).
Yasuda et al. (2008) show that deleting
ERK1 and ERK2 arrests B cell maturation
at checkpoint I. Asubstantial developmen-
tal block occurs only when the genes en-
coding both ERK1 and ERK2 are disrup-
ted, suggesting that these kinases are
redundant in early B cells. Thus, ERK1
and ERK2 are the critical targets of pre-
BCR signaling that drive the transition
through checkpoint I. ERK activation is
not only necessary for this step but also
sufficient, because expressing a constitu-
tively active form of MEK, the kinase that
activates ERK, rescues pre-BII cell prolif-
eration in B cell progenitors lacking Syk
and Zap70, a situation in which other pre-
BCR signaling pathways are disabled.
Moreover, expressing an IgH chain in
Rag1/ pro-B cells is sufficient to induce
ERK activation and proliferation in vitro,
supporting the idea that the pre-BCR
does not require a ligand to initiate signal-
ing and induce B cell maturation.Inc.A satisfying parallel is that ERK regu-
lates the analogous step in T cell develop-
ment, the b selection checkpoint where
pre-TCR signaling indicates production
of a functional TCR b chain. At the DN3
stage of thymocyte development, the
newly generated TCR b chain pairs with
the pre-Ta chain to form a pre-T cell re-
ceptor (pre-TCR). Pre-TCR signaling en-
forces allelic exclusion at the TCR b locus,
drives clonal expansion and differentia-
tion to the DN4 stage, and initiates TCR
a gene rearrangement. ERK2 is important
for pre-TCR-dependent thymocyte prolif-
eration but not for subsequent maturation
steps such as TCR a rearrangement
(Fischer et al., 2005). This parallel extends
to B cells in which another pre-BCR
signaling pathway, B cell linker protein
(BLNK; SLP65)- and Bruton’s tyrosine ki-
nase (Btk)-dependent activation of phos-
pholipase Cg2, controls the exit of
pre-BII cells from the cell cycle as they
downregulate SLC expression, produce
BCRs with k or l chains, and become im-
mature B cells (Jumaa et al., 2005). It is
not known whether ERK contributes to
this pre-BII to immature B cell transition.
How does ERK promote pre-B cell dif-
ferentiation and proliferation? Activated
ERK translocates to the nucleus and
phosphorylates transcription factors, so
looking for changes in gene expression
makes sense. To identify pre-BCR-regu-
lated genes, one needs to make pre-
BCR signaling inducible rather than
constitutive. Schuh et al. (2008) used
tetracycline-regulated induction of Igh
expression to initiate pre-BCR expres-
sion and signaling in Rag2/ B cell pro-
genitors. However, this limited them to
studying gene-expression changes that
occurred after 72 hr, when pre-BCR sig-
naling drives the pre-BII to immature B
cell transition.
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PreviewsFigure 1. ERK Controls a Transcription Factor Network that Allows B Cell Progenitors to
Traverse the Pro-B to Pre-BII Cell Checkpoint
At the end of the pro-B cell stage of B cell development, expression of a signaling-competent pre-BCR on
transitional pre-BI cells (fraction C of the early B cell lineage) represents a key checkpoint. Constitutive
signaling by the surrogate light chain (SLC)-containing pre-BCR promotes cell survival, terminates VDJ re-
combination at the Igh locus, induces phenotypic maturation to the CD2+CD25+ pre-BII stage (fraction C0 ),
and synergizes with IL-7 to drive clonal expansion. As pre-BII cells mature into immature B cells (not
shown), they exit the cell cycle, expression of the Vpre-B and l5 SLCs is downregulated, and the pre-
BCR is replaced by BCRs that contain k or l light chains. Yasuda et al. (2008) show that activation of
the ERK1 and ERK2 kinases by the pre-BCR is essential for this pro-B to pre-BII cell transition and identify
the ERK-dependent signaling pathways that promote pre-BII cell proliferation (box). ERK-dependent
phosphorylation of the ELK and CREB transcription factors leads to increased expression of the genes
encoding the c-Myc, Ilf2, Mef2C, and Mef2D transcription factors, all of which can promote the prolifera-
tive expansion of pre-BII cells. The dotted arrows suggest that ERK could also provide survival signals at
checkpoint I by increasing Bcl-2 expression and promoting degradation of the proapoptotic protein Bim.To look at early pre-BCR-induced
changes in gene expression, Yasuda
et al. (2008) used antibodies to cluster
the Iga-Igb signaling subunit on the sur-
face of pro-B cells isolated from mice
that lack the ability to make a functional
IgH chain. These IgH cells are normally
blocked at the pro-B cell stage, but initiat-
ing pre-BCR signaling in this manner
mimics pre-BCR signaling and drives the
cells through checkpoint I, thereby yield-
ing proliferating cells that are phenotypi-
cally pre-BII cells (CD2+CD25+). By doing
this in the presence or absence of U0126,
a specific inhibitor of ERK activation
by MEK, Yasuda et al. (2008) identified
rapid pre-BCR-induced gene-expression
changes that were dependent on ERK.
These changes in gene expression in-
cluded upregulation of genes encodingthe proliferation-associated transcription
factors c-Myc, c-Fos, Egr-1, Egr-2,
Egr-3, Fra-1, and Fra-2 as well as genes
encoding other transcription factors such
as Mef2c, Mef2d, Ilf2, and Hes5.
Expressing these transcription factors
one by one in ERK-deficient pro-B cells
revealed that only a subset of them,
c-Myc, Mef2c, Mef2d, and Ilf2, could by-
pass the loss of ERK signaling and restore
pre-BCR-dependent cell proliferation
in vitro. All four of these transcription fac-
tors are upregulated in pre-BII cells, sug-
gesting that they contribute to pre-BII cell
proliferation in vivo. But how can each of
them be sufficient to rescue pre-BII cell
proliferation? One possibility is that these
transcription factors have overlapping tar-
gets. Alternatively, expressing these pro-
teins in large amounts may bypass theImmneed for other components that normally
contribute to pre-BII cell proliferation. This
calls for loss-of-function approaches to
assess the normal functions of these pro-
teins in the checkpoint I transition.
Yasuda et al. (2008) used these target
genes as endpoints to fill in the steps
downstream of ERK. The Myc, Mef2c,
Mef2d, and Ilf2 promoters all contain
binding sites for Elk family transcription
factors, which are phosphorylated on
activating sites by ERK, and for CREB,
which is phosphorylated on its S119 acti-
vation site by ERK-mediated activation of
the RSK kinase. After finding that Iga-Igb
clustering induces ERK-dependent phos-
phorylation of Elk1 on S384 and CREB on
S119, they showed that expressing dom-
inant-negative forms of Elk or CREB lack-
ing ERK phosphorylation sites blocks
pre-BII cell expansion in vitro. This fits
with the finding that transgenic mice ex-
pressing the dominant-negative CREB
S119A protein in B lineage cells have the
same developmental block at the pro-B to
pre-B transition (Chen et al., 2006) as cells
lacking ERK1 and ERK2. Yasuda et al.
(2008) also showed that Myc and Ilf2 are
downstream of Elk, whereas Mef2c and
Mef2d are downstream of CREB, thereby
providing a complete pathway from ERK
to genes that are critical for pre-BII cell
expansion.
Elucidating how these Elk- and CREB-
regulated genes mediate the effects of
ERK on pre-B cells is an important future
direction. c-Myc is clearly critical for the
pro-B to pre-BII cell transition. Overex-
pressing c-Myc in Rag2/ mice allows
differentiation and expansion of pre-B
cells in the absence of pre-BCR signaling,
whereas B cell-specific deletion of c-Myc
andN-Myc blocks development at check-
point I (Habib et al., 2007). The relevant
targets of Myc remain to be identified.
Ilf2 regulates Il-2 expression in T cells.
Perhaps it regulates production of auto-
crine growth factors by B cell progenitors.
Mef2c andMef2d have been linked to leu-
kemogenesis, suggesting a role in prolif-
eration, but Mef2-regulated genes have
yet to be identified in B cells.
Understanding how ERK-regulated
transcription promotes pre-BII cell pro-
liferation could be advanced by identi-
fying pre-BCR-induced gene-expression
changes that dependonElk, CREB, c-Myc,
Ilf2, Mef2c, or Mef2d. Bcl2 expression is
induced by pre-BCR signaling via ERK,unity 28, April 2008 ª2008 Elsevier Inc. 489
Immunity
Previewsand probably CREB (Yasuda et al., 2008).
Pre-BCR signaling may also downregu-
late transcription factors that enforce qui-
escence. TIS21, a member of the BTG
(also known as TOB) family of transcrip-
tion factors, appears to keep thymocytes
quiescent prior to b-selection, and its
expression is downregulated by pre-TCR
signaling (Konrad and Zuniga-Pflucker,
2005).
ERK may also promote B cell develop-
ment by phosphorylating c-Myc, Bim,
and cyclin D3. This modification stabilizes
c-Myc and induces degradation of the
pro-apoptotic Bim protein. Cyclin D3 is
required for pre-B cell proliferation (Coo-
per et al., 2006). IL-7 induces its expres-
sion, but pre-BCR signaling via phospha-
tidylinositol 3-kinase protects cyclin D3
from degradation. The role of ERK in cy-
clin D3 stabilization has not been tested,
but phosphatidylinositol 3-kinase hasThe STATs on Den
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Dendritic cells are a heterogeneous
(2008) demonstrate how cytokine-re
subpopulation differentiation from h
Dendritic cells (DCs) are central regulators
in both priming of innate and adaptive
immune responses and in maintaining
self-tolerance. Multiple DC subsets have
been identified on the basis of their phe-
notype, location, maturation state, and
functional properties (Shortman and
Naik, 2007). In steady-state mouse lym-
phoid tissues, DCs can be classified in
at least two main populations, ‘‘plasma-
cytoid’’ DCs (pDCs) and conventional
DCs (cDCs), which can further be subdi-
vided into three subsets on the basis
of surface-molecule expression. Most
steady-state lymphoid tissue DCs have
a half-life of only few days and do not
490 Immunity 28, April 2008 ª2008 Elsevierbeen implicated in BCR-induced ERK
activation.
Yasuda et al. (2008) have provided im-
portant new molecular insights into how
the pre-BCR drives the pro-B to pre-BII
transition. Together with the identification
of genes that may regulate the pre-BII to
immature B cell transition (Schuh et al.,
2008), this forms the basis for a fuller
understanding of critical steps in B cell
development.
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cription factors direct dendritic cell
these questions has been acquired over
the last years.
Granulocyte-macrophage colony stim-
ulating factor (GM-CSF) with or without in-
terleukin-4 was first demonstrated to lead
to in vitro DC differentiation from whole
bone-marrow cells or monocytes in both
mice and man, and this efficient method
of DC generation is now frequently used
in both laboratory research and clinical
applications. However, only Flt3-ligand
stimulation of bone-marrow progenitors
induces generation of both pDCs and
cDCs, resembling DC populations in
lymphoid organs, whereas addition of
GM-CSF (with orwithout TNFa) to cultures
